Cognovi Labs Named PM360 Trailblazer 2021 Finalist for Company of the Year
Back to Newsroom
Mentioned in this Article

Cognovi Labs Named PM360 Trailblazer 2021 Finalist for Company of the Year

Monday, August 16, 2021 8:00 AM
Share this article now
Topic:
Company Update

COLUMBUS, OH / ACCESSWIRE / August 16, 2021 / PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics and medical device industries, named Cognovi Labs as a Trailblazer finalist for Vendor/ Supplier Company of the Year.

COGNOVI EMOTION AI™ is the latest advancement in Artificial Intelligence, generating real-time insight at scale about the precise emotions that drive decisions. A psychological foundation fused with deep machine learning enables Cognovi Labs to move steps beyond traditional market research, uncovering how patients and healthcare providers make subconscious decisions based on emotions. Cognovi Labs' capabilities are showcased in Emotion Trigger Marketing, a full-cycle digital marketing and communication program that identifies topics, phrases and narratives that motivate individuals toward optimal functioning.

'While Cognovi's Emotion AI is applicable anywhere people make decisions, the impact of COVID-19 on the global population has intensified our mission to use our technology for good," said Beni Gradwohl, Ph.D., Co-Founder and CEO of Cognovi Labs. 'We are determined to redefine patient-centered care through our proprietary Psychological AI, leveraging our tools to support the nation's efforts toward physical, social and mental wellbeing."

Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. The Company of the Year judging criteria included: Innovation (pursuit of excellence and innovation across the board in advertising, sales, product development, public relations and communication); Talent Development (a record of attracting, developing and keeping talent); and Social Responsibility (supporting patient access, civic and global involvement, and environmental consciousness).

"It's no secret that the reputation of companies in the life sciences industry has improved in ways we haven't seen in years," says Anna Stashower, CEO and Publisher of PM360. "That's because many companies, especially this year's finalists, proved how much they care about people by going above and beyond to donate, volunteer and serve their communities; support their employees and their families through these difficult years; and work around the clock to provide global hope through medicines, vaccines and other initiatives and campaigns with diverse social groups and underserved patients in mind."

Finalists are acknowledged and winners will be announced during a special virtual celebration on Thursday, September 23, at 6 pm EST. For more information about the awards or tickets to the virtual Trailblazer Awards Event, visit www.pm360online.com/trailblazer-tickets or contact Kayla Walsh at 646-300-8117 or [email protected].

# # #

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/ marketing, advertising/ promotion, patient/ professional education, sales, market research, PR and leadership.

About Cognovi Labs

People make decisions about companies, their services and products every day - whether we invite them to or not. Emotions drive most of these decisions, including those made by healthcare professionals and patients, often without awareness. Never before has anyone been able to scientifically anticipate these decisions before they are made in order to shape the outcome.

Cognovi Labs has developed a first-of-its-kind proprietary Emotion AI to provide this capability in real time and at scale. COGNOVI EMOTION AI™ integrates behavioral psychology with machine learning to analyze today's emotions to predict tomorrow's decisions. Cognovi's Emotion Trigger technology then identifies exact words, phrases and narratives which evoke the emotional responses that lead to a better future.

Media Contact:

Colin Butler, Global Revenue Officer
Email: [email protected]
www.cognovilabs.com

SOURCE: Cognovi Labs

Cognovi Labs
Back to Newsroom
{{msgBox.title}}

that

Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions